Antithymocyte globulin-induced hemolytic anemia and thrombocytopenia after kidney transplantation

Immunotherapy
T de NattesD Bertrand

Abstract

Antithymocyte globulin is the most widely used lymphocyte-depleting treatment in kidney transplantation. In spite of the frequency of side effects, including anemia and thrombocytopenia, their pathophysiological mechanisms are not clearly established. Here, we report the case of a 21-year-old patient who had a first kidney transplantation and received induction immunosuppressive therapy by thymoglobulin. Immediately after kidney transplantation, he developed a severe hemolytic anemia and thrombocytopenia with a subsequent perirenal hematoma, which lead to a second surgical procedure and a transfer to the intensive care unit. Our patients' anemia and thrombocytopenia had heteroimmune characteristics, and thymoglobulin therapy was suspected to be the cause, via an interaction with a common Fc-receptor epitope in the different cell lines.

References

May 1, 1985·American Journal of Hematology·J T PrchalM C Poon
Mar 29, 2002·American Journal of Hematology·Bradley C Gehrs, Richard C Friedberg
Aug 23, 2002·The New England Journal of Medicine·Joel L Moake
Jan 29, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Joshua SchwimmerMartin S Zand
Jun 5, 2003·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Hendrik Jan AnkersmitIvo Volf
Jun 8, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Albert J EidRaymund R Razonable
Jun 9, 2006·The New England Journal of Medicine·Lesley A StevensAndrew S Levey
Sep 12, 2006·Transplant International : Official Journal of the European Society for Organ Transplantation·Claudio Ponticelli, Giovanni Banfi
Nov 10, 2006·The New England Journal of Medicine·Daniel C BrennanUNKNOWN Thymoglobulin Induction Study Group
Aug 10, 2010·Nephron. Clinical Practice·Miklos Zsolt MolnarDavid J Goldsmith
May 28, 2011·Transfusion·Ruth AchkarJosé O Bordin
Oct 16, 2012·Clinical Transplantation·Georges MouradYvon Lebranchu
May 15, 2015·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·A CumpelikD Zecher

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.